RxDoctor Payments Data

Wesley Morris, PA

Physician Assistant · Casper, WYNPI 1548517659

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 36.7% of the total. Reporting peaked in 2021 at $402 and has fallen 95.3% since, to $19 in 2025.

$998in general payments, 2019–2025

Across 51 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$367
  • AstraZeneca$277
  • GSK$149
  • Lilly USA, LLC$81
  • Medtronic$36
  • Corium, LLC$27
  • plus $61 from 3 others

What the payments were for

  • Food & beverage$97898%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$998 in reported general payments places this provider in the 75th percentile of 203 physician assistant providers in Wyoming.

See all physician assistant providers in Wyoming

Medicare billing

Part B allowed, 2024
$12,957
Medicare patients
190
Services billed
1,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$51,278
FarxigaDapagliflozin Propanediol57$47,827
Breo ElliptaFluticasone/Vilanterol88$46,792
JardianceEmpagliflozin29$42,495
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$39,145
MounjaroTirzepatide27$27,611
OzempicSemaglutide27$25,708
TrulicityDulaglutide19$18,852
ArexvyRsvpref3 Antigen/As01e/Pf46$12,567
Spiriva HandihalerTiotropium Bromide14$10,470
ShingrixVaricella-Zoster Ge/As01b/Pf54$10,179
ReyvowLasmiditan Succinate11$8,199
Gabapentin188$5,381
Atorvastatin Calcium466$4,749
Ventolin HfaAlbuterol Sulfate50$4,427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta, Trelegy Ellipta, Arexvy, Shingrix, Incruse Ellipta$149$112,440245 claims
Lilly USA, LLCMounjaro, Trulicity, Reyvow$81$54,66257 claims
AstraZenecaFarxiga$277$47,82757 claims
AbbVieSynthroid$367$1,01011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 physician assistant providers in Wyoming.

Other physician assistant in Casper

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →